Erratum
Inhibitory Mechanism of the CXCR4 Antagonist T22 against Human Immunodeficiency Virus Type 1 Infection
Tsutomu Murakami, Tian-Yuan Zhang, Yoshio Koyanagi, Yuetsu Tanaka, Jin Kim, Yoichi Suzuki, Shigeru Minoguchi, Hirokazu Tamamura, Michinori Waki, Akiyoshi Matsumoto, Nobutaka Fujii, Hisatoshi Shida, James A. Hoxie, Stephen C. Peiper, Naoki Yamamoto
Tsutomu Murakami
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Tian-Yuan Zhang
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Yoshio Koyanagi
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Yuetsu Tanaka
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Jin Kim
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Yoichi Suzuki
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Shigeru Minoguchi
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Hirokazu Tamamura
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Michinori Waki
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Akiyoshi Matsumoto
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Nobutaka Fujii
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Hisatoshi Shida
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
James A. Hoxie
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Stephen C. Peiper
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
Naoki Yamamoto
Department of Microbiology and Molecular Virology, Faculty of Medicine, Tokyo Medical and Dental University,Bunkyo-ku, Tokyo 113-8519, University of the Ryukyus, Okinawa 903-0215, Institute for Virus Research,Kyoto University, Kyoto 606-01, Graduate School of Pharmaceutical Sciences, Kyoto University,Kyoto 606-8501, Seikagaku Corporation, Tokyo 103, and Department of Medical Chemistry,Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606, Japan; University of Louisville,Louisville, Kentucky 40202; Genentech, South San Francisco, California 94080; andUniversity of Pennsylvania, Philadelphia, Pennsylvania 19104
DOI: 10.1128/JVI.76.2.933.2002

- Copyright © 2002 American Society for Microbiology
Inhibitory Mechanism of the CXCR4 Antagonist T22 against Human Immunodeficiency Virus Type 1 Infection
Tsutomu Murakami, Tian-Yuan Zhang, Yoshio Koyanagi, Yuetsu Tanaka, Jin Kim, Yoichi Suzuki, Shigeru Minoguchi, Hirokazu Tamamura, Michinori Waki, Akiyoshi Matsumoto, Nobutaka Fujii, Hisatoshi Shida, James A. Hoxie, Stephen C. Peiper, Naoki Yamamoto
Journal of Virology Jan 2002, 76 (2) 933; DOI: 10.1128/JVI.76.2.933.2002
Inhibitory Mechanism of the CXCR4 Antagonist T22 against Human Immunodeficiency Virus Type 1 Infection
Tsutomu Murakami, Tian-Yuan Zhang, Yoshio Koyanagi, Yuetsu Tanaka, Jin Kim, Yoichi Suzuki, Shigeru Minoguchi, Hirokazu Tamamura, Michinori Waki, Akiyoshi Matsumoto, Nobutaka Fujii, Hisatoshi Shida, James A. Hoxie, Stephen C. Peiper, Naoki Yamamoto
Journal of Virology Jan 2002, 76 (2) 933; DOI: 10.1128/JVI.76.2.933.2002